. Author manuscript; available in PMC: 2023 Aug 1.

Published in final edited form as: J Subst Abuse Treat. 2022 Mar 18;139:108774. doi: 10.1016/j.jsat.2022.108774

Table 2.

Adjusted hazard of buprenorphine discontinuation in the first 6 months of treatment

	Unadjusted			Adjusted
	HR	95% CI	p-value	HR	95% CI	p-value

No therapy	Reference			Reference
Low-intensity therapy	0.55	0.53, 0.57	<0.001	0.55	0.54, 0.57	<0.001
High-intensity therapy	0.61	0.58, 0.63	<0.001	0.71	0.67, 0.74	<0.001

Abbreviations: HR, hazard ratio; CI, confidence interval

Note: Estimates were derived from fully adjusted Cox proportional hazards regression models estimating time to buprenorphine discontinuation; weighted estimates are based on multinomial propensity scores and represent the average treatment effect if all patients in the sample had followed a given therapy trajectory compared to all patients receiving no therapy.